Results 211 to 220 of about 382,305 (392)
Abstract Post‐translational modifications (PTMs) play a pivotal role in epigenetic regulation and are key pathways for modulating protein functionality. PTMs involve the covalent attachment of distinct chemical groups, such as succinyl, crotonyl, and lactyl, at specific protein sites, which alter protein structure, function, stability, and activity ...
Ting Wu+16 more
wiley +1 more source
When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. [PDF]
Yan Y, Tang YD, Zheng C.
europepmc +1 more source
Preliminary crysallization of a cyclin-dependent kinase inhibitor: P18 [PDF]
S. Jarchow, Hengming Ke
openalex +1 more source
Promising Prodiginins Biological Activities
ABSTRACT Prodiginins are a large family of at least 34 pyrrolic compounds, including the well‐studied red pigment prodigiosin. Prodiginins are produced by several microorganisms displaying broad biological activities, including antimicrobial, antiviral, antiparasitic, antiproliferative, and immunosuppressive activities.
María F. Ladetto+6 more
wiley +1 more source
Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation. [PDF]
Ford K+18 more
europepmc +1 more source
Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1 [PDF]
Keiju Hiromura+4 more
openalex +1 more source
Eugenia brasiliensis: Analysis of the Chemical Profile and Evaluation of Cytotoxic Potential
Leaves of Eugenia brasiliensis were dried, crushed and macerated with polarity increment. The antiporliferative and anti‐migratory potential and the cell cycle were evaluated. 28 compounds were tentatively identified by mass sceptrometry. ABSTRACT This work evaluated the antiproliferative potential of Eugenia brasiliensis leaf extracts against the HeLa
Giovana G. F. V. de Oliveira+9 more
wiley +1 more source
Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma. [PDF]
Mo C+9 more
europepmc +1 more source
Inhibitors of cyclin‐dependent kinases as cancer therapeutics
S. Whittaker+3 more
semanticscholar +1 more source